Cargando…

S297: CANCER RISK IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA – A DANISH NATIONWIDE COHORT STUDY

Detalles Bibliográficos
Autores principales:	Mannering, Nikolaj, Lund Hansen, Dennis, Lafaurie, Margaux, Pottegård, Anton, Moulis, Guillaume, Frederiksen, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428509/ http://dx.doi.org/10.1097/01.HS9.0000968100.11496.12

Ejemplares similares

Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population‐based study
por: Mannering, Nikolaj, et al.
Publicado: (2023)

Evans syndrome in children below 13 years of age – A nationwide population-based cohort study
por: Mannering, Nikolaj, et al.
Publicado: (2020)

S302: LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF THE ADVANCE+ STUDY
por: Carpenedo, Monica, et al.
Publicado: (2023)

S299: ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON’S TYROSINE KINASE, FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: RESULTS OF A RANDOMIZED, OPEN-LABEL PHASE II STUDY
por: Shi, Yan, et al.
Publicado: (2023)

S295: TACROLIMUS MODULATES CD4+ T-CELL PROLIFERATION AND FUNCTION VIA MTHFD2 IN IMMUNE THROMBOCYTOPENIA
por: Yang, LI-Ping, et al.
Publicado: (2023)

S296: IL-1Β SIGNALLING INDUCES, AND BARICITINIB ALLEVIATES NEU1-MEDIATED MEGAKARYOCYTE DESIALYLATION IN IMMUNE THROMBOCYTOPENIA
por: Zhao, Peng, et al.
Publicado: (2023)

S298: MATERNAL AND FETAL OUTCOMES IN PREGNANCIES OF WOMEN WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER RETROSPECTIVE OBSERVATIONAL ITP-NET ITALIAN STUDY
por: Carpenedo, Monica, et al.
Publicado: (2023)

Validation of Discharge Diagnosis of Sickle Cell Disease Vaso-Occlusive Episodes in the French Hospital Electronic Database
por: Walter, Ondine, et al.
Publicado: (2021)

Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study
por: Moulis, Guillaume, et al.
Publicado: (2015)

S265: MATERNAL AND PERINATAL OUTCOMES OF SICKLE CELL DISEASE IN PREGNANCY: A NATIONWIDE STUDY IN FRANCE.
por: Corsia, Alice, et al.
Publicado: (2023)

Positive predictive value of diagnosis coding for hemolytic anemias in the Danish National Patient Register
por: Hansen, Dennis Lund, et al.
Publicado: (2016)

Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study
por: Pottegård, Anton, et al.
Publicado: (2014)

P297 Disseminated histoplasmosis from skin to adrenals a cosmetic catastrophe—a rare case report
por: R, NEETHA T, et al.
Publicado: (2022)

Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow‐up
por: Hansen, Dennis Lund, et al.
Publicado: (2022)

Impact of previous exposure to systemic corticosteroids on unfavorable outcome in patients hospitalized for COVID-19
por: Lafaurie, Margaux, et al.
Publicado: (2021)

Comparison of the first and second waves of coronavirus disease in Toulouse, France
por: Jourdes, Aurelie, et al.
Publicado: (2022)

Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study
por: Reilev, Mette, et al.
Publicado: (2017)

Antiplatelet drugs and breast cancer risk in a large nationwide Danish case‐control study
por: Cairat, Manon, et al.
Publicado: (2022)

S108: ATP CITRATE LYASE IS AN ESSENTIAL PLAYER OF THE METABOLIC REWIRING INDUCED BY PTEN LOSS DURING T-ALL DEVELOPMENT
por: Andrieu, Guillaume, et al.
Publicado: (2023)

S205: INHIBITING THE ALARMIN-DRIVEN HEMATOPOIESIS-STROMAL CELLS CROSSTALK IN PRIMARY MYELOFIBROSIS AMELIORATES BONE MARROW FIBROSIS
por: Gleitz, Hélène, et al.
Publicado: (2023)

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONSE MAINTENANCE IN CHRONIC MYELOID LEUKAEMIA PATIENTS IN THE EUROPEAN STOP KINASE INHIBITORS (EURO-SKI) TRIAL
por: Pfirrmann, Markus, et al.
Publicado: (2023)

WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
por: Lotti, V., et al.
Publicado: (2022)

S232: EFFICACY AND TOXICITY OF CAR-T CELLS IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMAS, A NEW REFERENCE: THE FRENCH EXPERIENCE OF THE NATIONAL LOC NETWORK
por: Choquet, Sylvain, et al.
Publicado: (2023)

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA AFTER DISCONTINUATION OF TYROSINE KINASE INHIBITORS: RESULTS FROM THE EURO-SKI STUDY
por: Efficace, Fabio, et al.
Publicado: (2023)

S234: CLINICAL-GRADE MBIL21/4-1BBL EXPANDED NK CELLS EXHIBIT STRONGER COMPETENCE COMPARED WITH PRIMARY NK CELLS AGAINST HCMV INFECTION
por: Shang, Q.-N., et al.
Publicado: (2022)

S245: RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAIVE OR STEROID-REFRACTORY CHRONIC GRAFT VERSUS HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE II REACH5 STUDY
por: Locatelli, Franco, et al.
Publicado: (2023)

S211: EFFICACY AND SAFETY OF ROPEGINTERFERON ALFA-2B FOR PRE-FIBROTIC PRIMARY MYELOFIBROSIS AND DIPSS LOW/INTERMEDIATE-1 RISK MYELOFIBROSIS: UPDATED RESULTS AND GENOMIC CHARACTERISTICS
por: Gill, Harry, et al.
Publicado: (2023)

S231: PRIMARY MEDIASTINAL B-CELL LYMPHOMA HAVE A SUPERIOR OUTCOME COMPARED TO DIFFUSE LARGE-B-CELL LYMPHOMA TREATED WITH AXICABTAGENE CILOLEUCEL IN THE CART-SIE REAL LIFE ITALIAN STUDY
por: Chiappella, Annalisa, et al.
Publicado: (2023)

O7.2. MENTAL HEALTH AND SOMATIC STATUS OF YOUNG CHILDREN (0–6 YEARS) BORN TO PARENTS WITH SEVERE MENTAL ILLNESSES - A NATIONWIDE DANISH REGISTER STUDY
por: Amalie Thorup, Anne, et al.
Publicado: (2020)

S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX
por: Mascarenhas, John, et al.
Publicado: (2023)

S106: METABOLIC PLASTICITY REVEALS A TARGETABLE VULNERABILITY IN LEUKEMIA
por: Andrieu, Guillaume, et al.
Publicado: (2023)

S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
por: Demaria, Olivier, et al.
Publicado: (2023)

Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study
por: Pottegård, Anton, et al.
Publicado: (2018)

S160: GATA2B HAPLOINSUFFICIENCY CAUSES ABERRANT TRANSCRIPTIONAL REGULATORY SIGNATURES IN HSPCS RESULTING IN MYELOID AND ERYTHROID DYSPLASIA IN ZEBRAFISH
por: Zhang, Wei, et al.
Publicado: (2023)

S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM THE NCRI AML18 TRIAL
por: Knapper, Steven, et al.
Publicado: (2023)

A New Tool to Assess the Epidemiology of Immune Thrombocytopenia: The Nordic Country Patient Registry for Romiplostim
por: Moulis, Guillaume
Publicado: (2019)

Infections inhabituelles
Publicado: (2011)

Grippe A (H1N1) en réanimation
Publicado: (2010)

ECMO veinoveineuse
Publicado: (2013)

S238: CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY
por: Loyaux, Romain, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ch3tdt6go4ri500r1gevs7sqkc